http://ift.tt/eA8V8J
LEUVEN, Belgium, May 11, 2017 /PRNewswire/ —
Progressing Innovative Diabetic Eye Disease Clinical and Pre-Clinical Portfolio
Highlights
ThromboGenics continues to focus on progressing its portfolio of novel medicines for the treatment of diabetic eye disease…
May 11, 2017 at 09:01PM
from
No comments:
Post a Comment